Alliance Capital Partners is a private equity general partner firm headquartered in New York, NY, United States.
Allianz Capital Partners spices up its PE portfolio with a smattering of ‘riskier’ funds and is considering investing in Africa.
VC-backed GlycoMimetics, a biotech company focused on developing glycomimetic drugs, has filed for an IPO.
Allianz Capital Partners has acquired the 20MW Haut Chemin wind farm in France for an undisclosed sum.
Read more news concerning Alliance Capital Partners
A sampling of Alliance Capital Partners portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?